FDA Health Law Policy History Jonathan Perez-Reyzin Market Design Public Health Scientific Evidence Tobacco Mushroom Monographs? The FDA’s Potential Role in a Legal Recreational Drug Market Read more: Mushroom Monographs? The FDA’s Potential Role in a Legal Recreational Drug Market
Contributors FDA Health Law Policy Human Subjects Research Immunization Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
aging Beatrice Brown FDA Featured Geriatrics Health Care Finance Health Care Reform Medical Quality Medical Safety Medicare/Medicaid Patient Care Pharmaceuticals Public Health Resource Allocation FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision? Read more: FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Vaccines What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)? Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?
aging Emily Largent FDA Featured Geriatrics Health Care Finance Health Care Reform Medical Quality Medical Safety Medicare/Medicaid Patient Care Pharmaceuticals Public Health Resource Allocation Aducanumab: A Bitter Pill to Swallow Read more: Aducanumab: A Bitter Pill to Swallow
Addiction Criminal Law Dustin Marlan FDA Health Law Policy Medical Safety Mental Health Neuroscience Opioid Crisis Patient Care Pharmaceuticals Public Health Race Scientific Evidence A Sensible, Evidence-Based Proposal for Kratom Reform Read more: A Sensible, Evidence-Based Proposal for Kratom Reform
Arthur Caplan Bioethics FDA Health Law Policy Human Subjects Research Market Design Medical Quality Medical Safety Patient Care Pharmaceuticals Professional Regulation Public Health Scientific Evidence Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal Read more: Expanding The Right to Try Unproven Treatments: A Dangerous, Deregulatory Proposal